(Downloading may take up to 30 seconds.
If the slide opens in your browser, select File -> Save As to save it.)
Click on image to view larger version.

Fig. 5. SRF interacts with Smad2. (A) 293T cells were transfected
with HA-tagged SRF and Flag-tagged Smad2 with or without constitutively active
Activin type-I receptor (ALK4*). Cell lysates were
immunoprecipitated (IP) with anti-Flag antibody, followed by immunoblotting
(IB) with anti-HA antibody to detect Smad-bound SRF. (B,C) Interaction
of endogenous SRF and Smad2 was examined in Mv1Lu and HeLa cells. (B) Mv1Lu
cells were left untreated or treated with Activin A for 1 hour. Cell lysates
were subjected to IP with anti-SRF rabbit polyclonal antibody, followed by IB
with an anti-Smad2 mouse monoclonal antibody. (C) HeLa cell lysates were
subjected to IP with anti-SRF antibody, followed by IB with anti-Smad2
antibody. This was repeated in reverse order. (D) Schematic of Smad2
truncation mutants. (E) Flag-tagged Smad2 deletion mutants were
transfected into 293T cells together with GST-SRF. Cell lysates were pulled
down by glutathione-agarose beads and then immunoblotted with antiFlag
antibody.